University of Minnesota. Driven to Discover.
More states are reporting their first cases and even deaths, but at the national level, flu levels remained low last week.
The study of VSV-EBOV hopes to enroll 6,000 health and other frontline workers.
The first two phase 1 trials of VSV-EBOV vaccine show good immune responses.
With its Mar 7 launch date, the trial's main goal is to see if ring vaccination can knock down Ebola hot spots.
An international team of experts says, in effect, "Don't be so sure" about Ebola not spreading by air.
A British Columbia resident who recently returned from China is recovering from H7N9 avian flu.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.